| http://www.w3.org/ns/prov#value | - by Krista Conger (Medical Xpress)???Recently some intriguing data has suggested that breast cancer patients whose tumors appear insensitive to a class of drugs known as anti-HER2 medications (the drug trastuzumab, marketed as Herceptin, is a well-known example) may somehow still benefit from treatment with the medication.
|
